Enhabit (NYSE:EHAB) Updates FY 2025 Earnings Guidance

Enhabit (NYSE:EHABGet Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 0.500-0.560 for the period, compared to the consensus EPS estimate of 0.560. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Enhabit Trading Up 1.1%

EHAB stock opened at $9.48 on Thursday. Enhabit has a one year low of $6.47 and a one year high of $10.90. The stock has a market cap of $479.78 million, a price-to-earnings ratio of -37.92 and a beta of 1.67. The company has a fifty day moving average price of $8.76 and a two-hundred day moving average price of $8.24. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.58 and a quick ratio of 1.58.

Enhabit (NYSE:EHABGet Free Report) last posted its earnings results on Wednesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.05. The company had revenue of $263.60 million during the quarter, compared to analysts’ expectations of $267.08 million. Enhabit had a negative net margin of 1.14% and a positive return on equity of 3.91%. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. Equities analysts anticipate that Enhabit will post 0.22 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Enhabit in a report on Monday. Jefferies Financial Group restated a “buy” rating on shares of Enhabit in a research note on Tuesday, December 16th. Finally, Citigroup reaffirmed a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Enhabit has a consensus rating of “Hold” and a consensus target price of $8.50.

View Our Latest Analysis on Enhabit

Institutional Trading of Enhabit

Several large investors have recently modified their holdings of EHAB. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Enhabit by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock valued at $262,000 after purchasing an additional 1,248 shares during the last quarter. Orion Porfolio Solutions LLC lifted its stake in shares of Enhabit by 1.0% in the 3rd quarter. Orion Porfolio Solutions LLC now owns 144,016 shares of the company’s stock valued at $1,154,000 after acquiring an additional 1,361 shares during the last quarter. Osaic Holdings Inc. lifted its stake in shares of Enhabit by 337.5% in the 2nd quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock valued at $25,000 after acquiring an additional 2,018 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of Enhabit by 82.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock valued at $44,000 after acquiring an additional 2,059 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its position in Enhabit by 11.0% during the 2nd quarter. BNP Paribas Financial Markets now owns 23,742 shares of the company’s stock worth $229,000 after acquiring an additional 2,350 shares during the last quarter.

Enhabit Company Profile

(Get Free Report)

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.

Read More

Earnings History and Estimates for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.